Table 2 Characteristics of gastric cancer in patients with and without DM after H. pylori eradication therapy
From: Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients
Total (n = 21) | Non-DM (n = 9) | DM (n = 12) | p |
|---|---|---|---|
Mean age (range), years | 69.4 (56–80) | 70.6 (60–78) | 0.7137 |
Sex, n (%) | 0.5533 | ||
Female | 2 (22.2 %) | 1 (8.33 %) | |
Male | 7 (77.8 %) | 11 (91.7 %) | |
Mean follow up period (range), years | 4.59 (1.03–11.8) | 3.95 (0.95–7.15) | 0.6990 |
Mean endoscopy interval (range), years | 1.93 (0.99–4.06) | 1.62 (0.70–2.95) | 0.2527 |
Mean body mass index (range), kg/m2 | 23.4 (19.5–27.5) | 22.6 (19.0–30.1) | 0.5534 |
Atrophic gastritis, n (%) | 0.2030 | ||
Mild | 0 | 0 | |
Moderate | 5 (55.6 %) | 3 (25.0 %) | |
Severe | 4 (44.4 %) | 9 (75.0 %) | |
Pathology, n (%) | 0.3383 | ||
Intestinal type | 8 (88.9 %) | 8 (66.7 %) | |
Diffuse type | 1 (11.1 %) | 4 (33.3 %) | |
Diameter, mm | 22.1 (3–70) | 25.0 (5–60) | 0.7543 |
Depth, n (%) | 0.2562 | ||
Mucosa | 6 (66.7 %) | 5 (41.7 %) | |
Submucosa and deeper | 3 (33.3 %) | 7 (58.3 %) | |
Location, n (%) | 0.7332 | ||
Upper third | 3 (33.3 %) | 2 (16.7 %) | |
Middle third | 3 (33.3 %) | 5 (41.7 %) | |
Lower third | 3 (33.3 %) | 5 (41.7 %) | |
Treatment, n (%) | 0.3869 | ||
Endoscopic | 6 (66.7 %) | 5 (41.7 %) | |
Surgery | 3 (33.3 %) | 7 (58.3 %) |